Eye News and Research

Latest Eye News and Research

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA.

20 May 2013

First Edition: May 20, 2013

Today's headlines include reports about the policy and political issues currently surrounding the health law's implementation.

20 May 2013

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer.

20 May 2013

Republicans pressing link between Obamacare and IRS scandal

News coverage of the ongoing IRS scandal is focusing on Republican criticism of Sarah Hall Ingram, who is now in charge of helping to implement the health care law.

20 May 2013

Study: VEGF inhibitor appears to improve glaucoma surgical outcomes

The most common cause of failure after glaucoma surgery is scarring at the surgical site, so researchers are actively looking for ways to minimize or prevent scar formation. Previous work had suggested that vascular endothelial growth factor (VEGF) activates fibrosis, whereas VEGF inhibition results in reduced scar formation and better surgical results.

18 May 2013

Study reveals that heart disease risk factor management differs among outpatient practices

Control of heart disease risk factors varies widely among outpatient practices, according to a study presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013.

17 May 2013

Controversy lurks as cloning technique yields embryos with eye on stem cell therapies

Political and ethical fights over human cloning may follow the latest stem cell therapy advance after scientists created embryos that are genetic copies of living people in an effort to treat diseases such as Alzheimer's.

17 May 2013

Research sheds new light on occupation-specific rehabilitation

After cardiac surgery, should a farmer and an attorney take the same physical test to be found fit for work? They do now. But new research from Jenny Adams, PhD, at Baylor Health Care System's Baylor Hamilton Heart and Vascular Hospital, could change that.

16 May 2013

Hospitals: Calif. bidding war intensifies; Va. system eyes children's facility

The business of hospitals makes news in California -- where sides are engaged in a bidding war to buy a famed Santa Monica hospital; Virginia -- where pediatricians eye a new children's hospital; and Oregon, where lawmakers passed a new hospital tax.

16 May 2013

Sigma-Tau Pharmaceuticals recognized as a rare disease pioneer

Sigma-Tau Pharmaceuticals, Inc. announced today that the Company was recognized last evening as a rare disease pioneer at the 30th anniversary celebration of The National Organization for Rare Disorders.

15 May 2013

New study reveals another duet played by Notch and BMP signals

A small ensemble of musicians can produce an infinite number of melodies, harmonies and rhythms. So too, do a handful of workhorse signaling pathways that interact to construct multiple structures that comprise the vertebrate body.

15 May 2013

Fish oil supplements may not alter progression of age-related macular degeneration, say researchers

A large-scale National Eye Institute study has shown fish oil supplements containing omega-3 fatty acids do not alter the progression of age-related macular degeneration, says a national team of researchers including David M. Brown, M.D., an retina specialist at The Methodist Hospital who ran Houston's part of the study.

14 May 2013

Study: Rb plays critical role in maintaining starvation-induced transcriptome

A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division -- the hallmark of the disease -- it also can help make cells more fit by allowing them to fend off stress, says a University of Colorado Boulder study.

13 May 2013

UC Berkeley vision scientists pinpoint how the brain tracks fast-moving objects

How does San Francisco Giants slugger Pablo Sandoval swat a 95 mph fastball, or tennis icon Venus Williams see the oncoming ball, let alone return her sister Serena's 120 mph serves? For the first time, vision scientists at the University of California, Berkeley, have pinpointed how the brain tracks fast-moving objects.

9 May 2013

Phase 1b clinical study data of EBI-005 for treatment of dry eye disease presented at ARVO meeting

Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.

9 May 2013

Massachusetts hospital performs first cornea transplant with pre-loaded donor tissue

The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service at Mass. Eye and Ear, and an Associate Professor of Ophthalmology at Harvard Medical School, recently performed the groundbreaking transplant.

8 May 2013

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain is caused by lesion or disease to the peripheral somatosensory nervous system. Nerve damage that can lead to peripheral neuropathic pain can happen as a result of a range of different diseases, medications or traumatic injuries.

8 May 2013

New skin cancer drug successfully tested in humans

A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye diseases.

8 May 2013

Rigel reports net loss of $25.6 million in first quarter 2013

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2013. For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012. Weighted average shares outstanding for the first quarters of 2013 and 2012 were 87.1 million and 71.4 million, respectively.

7 May 2013

New form of electroconvulsive therapy could prevent adverse cognitive side effects

Electroconvulsive therapy (ECT) is the most effective acute treatment for severe major depression. However, even with newer forms of ECT, there remains a significant risk of adverse cognitive effects, particularly memory problems.

7 May 2013

Eye News and Research

Latest Eye News and Research

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

First Edition: May 20, 2013

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

Republicans pressing link between Obamacare and IRS scandal

Study: VEGF inhibitor appears to improve glaucoma surgical outcomes

Study reveals that heart disease risk factor management differs among outpatient practices

Controversy lurks as cloning technique yields embryos with eye on stem cell therapies

Research sheds new light on occupation-specific rehabilitation

Hospitals: Calif. bidding war intensifies; Va. system eyes children's facility

Sigma-Tau Pharmaceuticals recognized as a rare disease pioneer

New study reveals another duet played by Notch and BMP signals

Fish oil supplements may not alter progression of age-related macular degeneration, say researchers

Study: Rb plays critical role in maintaining starvation-induced transcriptome

UC Berkeley vision scientists pinpoint how the brain tracks fast-moving objects

Phase 1b clinical study data of EBI-005 for treatment of dry eye disease presented at ARVO meeting

Massachusetts hospital performs first cornea transplant with pre-loaded donor tissue

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

New skin cancer drug successfully tested in humans

Rigel reports net loss of $25.6 million in first quarter 2013

New form of electroconvulsive therapy could prevent adverse cognitive side effects

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Eye News and Research

Latest Eye News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in